Atea Pharmaceuticals Inc (AVIR)

Atea Pharmaceuticals Inc (AVIR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $413M; returns 1 day -0.2%, 1 week -6.5%, 1 year +26.6%.

Atea Pharmaceuticals Inc. (AVIR) is a clinical-stage biopharmaceutical company focused on discovering and developing oral antiviral therapeutics for serious viral diseases. Their primary focus is on single-stranded ribonucleic acid (ssRNA) viruses.

Groups AVIR belongs to

• Buying Back Stock
• Clinical Stage Biopharma
• Antivirals
• Biotechnology
• Healthcare
• Biopharmaceutical
• Pharmaceuticals
• Infectious Diseases
• Liver Disease
• Clinical Stage
• Drug Discovery

AVIR financial model: income statement, cash flow and balance sheet